3-(3-(5-(1H-Pyrrolo[2,3-b]pyridin-2-yl)-1H-1,2,3-triazol-1-yl)propyl)-1H-pyrrolo[2,3-b]pyridine

ID: ALA3763161

Chembl Id: CHEMBL3763161

PubChem CID: 136380883

Max Phase: Preclinical

Molecular Formula: C19H17N7

Molecular Weight: 343.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  c1cnc2[nH]c(-c3cnnn3CCCc3c[nH]c4ncccc34)cc2c1

Standard InChI:  InChI=1S/C19H17N7/c1-4-13-10-16(24-18(13)20-7-1)17-12-23-25-26(17)9-3-5-14-11-22-19-15(14)6-2-8-21-19/h1-2,4,6-8,10-12H,3,5,9H2,(H,20,24)(H,21,22)

Standard InChI Key:  XZHYCSATQUPVQG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3763161

    ---

Associated Targets(Human)

CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E1 (1877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
G-361 (890 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK1 Tchem Cyclin-dependent kinase 1/cyclin B1 (1887 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK4 Tclin Cyclin-dependent kinase 4/cyclin D1 (2340 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNH Tbio CDK7/Cyclin H/MNAT1 (693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNT1 Tchem CDK9/cyclin T1 (2643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 343.39Molecular Weight (Monoisotopic): 343.1545AlogP: 3.33#Rotatable Bonds: 5
Polar Surface Area: 88.07Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.43CX Basic pKa: 3.68CX LogP: 2.46CX LogD: 2.46
Aromatic Rings: 5Heavy Atoms: 26QED Weighted: 0.51Np Likeness Score: -1.16

References

1. Baltus CB, Jorda R, Marot C, Berka K, Bazgier V, Kryštof V, Prié G, Viaud-Massuard MC..  (2016)  Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors.,  108  [PMID:26741853] [10.1016/j.ejmech.2015.12.023]

Source